Literature DB >> 12489940

Pyranmycins, a novel class of aminoglycosides with improved acid stability: the SAR of D-pyranoses on ring III of pyranmycin.

Cheng-Wei Tom Chang1, Yu Hui, Bryan Elchert, Jinhua Wang, Jie Li, Ravi Rai.   

Abstract

[reaction: see text] The synthesis of a novel class of aminoglycosides, pyranmycins, is reported along with the structure activity relationship (SAR) of their antibacterial activity against Escherichia coli. Two pyranmycins show prominent activity (9 microM). Pyranmycins also manifest superior stability in acidic media. The SAR information will lead to the future designs of pyranmycin against drug resistant bacteria.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12489940     DOI: 10.1021/ol0269042

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  15 in total

1.  When Proteins Start to Make Sense: Fine-tuning Aminoglycosides for PTC Suppression Therapy.

Authors:  Moran Shalev; Timor Baasov
Journal:  Medchemcomm       Date:  2014-08-01       Impact factor: 3.597

2.  A review of patents (2011-2015) towards combating resistance to and toxicity of aminoglycosides.

Authors:  Nishad Thamban Chandrika; Sylvie Garneau-Tsodikova
Journal:  Medchemcomm       Date:  2015-11-19       Impact factor: 3.597

Review 3.  Comprehensive review of chemical strategies for the preparation of new aminoglycosides and their biological activities.

Authors:  Nishad Thamban Chandrika; Sylvie Garneau-Tsodikova
Journal:  Chem Soc Rev       Date:  2018-02-19       Impact factor: 54.564

4.  Antifungal Amphiphilic Aminoglycosides.

Authors:  C-W T Chang; J Y Takemoto
Journal:  Medchemcomm       Date:  2014-08-01       Impact factor: 3.597

5.  The design and synthesis of an α-Gal trisaccharide epitope that provides a highly specific anti-Gal immune response.

Authors:  Kensaku Anraku; Shun Sato; Nicholas T Jacob; Lisa M Eubanks; Beverly A Ellis; Kim D Janda
Journal:  Org Biomol Chem       Date:  2017-04-05       Impact factor: 3.876

6.  Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts.

Authors:  Virginia B Mattis; Ravi Rai; Jinhua Wang; Cheng-Wei T Chang; Tristan Coady; Christian L Lorson
Journal:  Hum Genet       Date:  2006-09-02       Impact factor: 4.132

Review 7.  Therapeutics based on stop codon readthrough.

Authors:  Kim M Keeling; Xiaojiao Xue; Gwen Gunn; David M Bedwell
Journal:  Annu Rev Genomics Hum Genet       Date:  2014-04-18       Impact factor: 8.929

8.  Synthesis and antibacterial activity of pyranmycin derivatives with N-1 and O-6 modifications.

Authors:  Jie Li; Fang-I Chiang; Hsiao-Nung Chen; Cheng-Wei Tom Chang
Journal:  Bioorg Med Chem       Date:  2007-09-01       Impact factor: 3.641

Review 9.  Antifungal amphiphilic kanamycins: new life for an old drug.

Authors:  Yagya Prasad Subedi; Madher N AlFindee; Jon Y Takemoto; Cheng-Wei Tom Chang
Journal:  Medchemcomm       Date:  2018-04-17       Impact factor: 3.597

10.  Subcutaneous administration of TC007 reduces disease severity in an animal model of SMA.

Authors:  Virginia B Mattis; Marina Y Fosso; Cheng-Wei Chang; Christian L Lorson
Journal:  BMC Neurosci       Date:  2009-11-30       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.